Impact of C-reactive protein and albumin levels on short, medium, and long term mortality in patients with diffuse large B-cell lymphoma.

MLA

Gradel, Kim Oren, et al. “Impact of C-Reactive Protein and Albumin Levels on Short, Medium, and Long Term Mortality in Patients with Diffuse Large B-Cell Lymphoma.” Annals of Medicine, vol. 54, no. 1, Dec. 2022, pp. 713–22. EBSCOhost, https://doi.org/10.1080/07853890.2022.2046287.

APA

Gradel, K. O., Larsen, T. S., Frederiksen, H., Vinholt, P. J., Iachina, M., Póvoa, P., Zampieri, F. G., Nielsen, S. L., Dessau, R. B., Møller, J. K., Jensen, T. G., Chen, M., Coia, J. E., & Jelicic, J. (2022). Impact of C-reactive protein and albumin levels on short, medium, and long term mortality in patients with diffuse large B-cell lymphoma. Annals of Medicine, 54(1), 713–722. https://doi.org/10.1080/07853890.2022.2046287

Chicago

Gradel, Kim Oren, Thomas Stauffer Larsen, Henrik Frederiksen, Pernille Just Vinholt, Maria Iachina, Pedro Póvoa, Fernando Godinho Zampieri, et al. 2022. “Impact of C-Reactive Protein and Albumin Levels on Short, Medium, and Long Term Mortality in Patients with Diffuse Large B-Cell Lymphoma.” Annals of Medicine 54 (1): 713–22. doi:10.1080/07853890.2022.2046287.